VEXAS Syndrome Complicated by Myelodysplastic Syndromes: A Report of Two Cases and Review of Therapeutic Challenges

VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) is a refractory, autoimmune, inflammatory disease caused by somatic mutations in ubiquitin-like modifier activating enzyme 1 (UBA1) gene. It is characterized by systemic inflammatory responses and hematologic abnormalities. This case report describes two male patients with VEXAS syndrome coexisting with myelodysplastic syndrome (MDS). Both patients were treated with high-dose corticosteroids to control inflammatory responses. Patient 1 developed hemophagocytic lymphohistiocytosis after immunosuppressive therapy; azacitidine treatment was ineffective, and the patient eventually died of severe pneumonia. Patient 2 developed antiphospholipid syndrome with an increased proportion of ring sideroblasts. The patient received azacitidine combined with ruxolitinib, which partially improved the inflammatory symptoms and blood counts; however, transfusion dependence persisted. Patient 2 later developed persistent fever difficult to control and died. Although glucocorticoids reduce inflammation, patients often remain dependent on them. The hypomethylating agent, azacitidine, shows limited efficacy, whereas Janus kinase inhibitors such as ruxolitinib may improve inflammatory symptoms. These cases underscore the importance of early detection of UBA1 mutations and highlight the clinical challenges associated with VEXAS syndrome coexisting with MDS. Early multidisciplinary collaboration is thus essential, and further research is needed to develop effective therapeutic strategies.

Authors

Publication Details

Journal
Transfusion Medicine and Hemotherapy
Published
2026-11-21
DOI
https://doi.org/10.1159/tmh/aevag014
Primary Topic
Autoimmune and Inflammatory Disorders Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

VEXAS Syndrome Complicated by Myelodysplastic Syndromes: A Report of Two Cases and Review of Therapeutic Challenges

Zeyan Shi, Yuan Long, Hao Liang, Zeguang Wu et al.
Transfusion Medicine and Hemotherapy
Autoimmune and Inflammatory Disorders Research
article

VEXAS Syndrome Complicated by Myelodysplastic Syndromes: A Report of Two Cases and Review of Therapeutic Challenges

Zeyan Shi, Yuan Long, Hao Liang, Zeguang Wu, Zhengfang Liu, Wenqiang Xie
article en

Abstract

VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) is a refractory, autoimmune, inflammatory disease caused by somatic mutations in ubiquitin-like modifier activating enzyme 1 (UBA1) gene. It is characterized by systemic inflammatory responses and hematologic abnormalities. This case report describes two male patients with VEXAS syndrome coexisting with myelodysplastic syndrome (MDS). Both patients were treated with high-dose corticosteroids to control inflammatory responses. Patient 1 developed hemophagocytic lymphohistiocytosis after immunosuppressive therapy; azacitidine treatment was ineffective, and the patient eventually died of severe pneumonia. Patient 2 developed antiphospholipid syndrome with an increased proportion of ring sideroblasts. The patient received azacitidine combined with ruxolitinib, which partially improved the inflammatory symptoms and blood counts; however, transfusion dependence persisted. Patient 2 later developed persistent fever difficult to control and died. Although glucocorticoids reduce inflammation, patients often remain dependent on them. The hypomethylating agent, azacitidine, shows limited efficacy, whereas Janus kinase inhibitors such as ruxolitinib may improve inflammatory symptoms. These cases underscore the importance of early detection of UBA1 mutations and highlight the clinical challenges associated with VEXAS syndrome coexisting with MDS. Early multidisciplinary collaboration is thus essential, and further research is needed to develop effective therapeutic strategies.

Transfusion Medicine and Hemotherapy
Autoimmune and Inflammatory Disorders Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon